PRICE T ROWE ASSOCIATES INC /MD/ - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 96 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$29,000
-21.6%
34,4000.0%0.00%
Q2 2022$37,000
-33.9%
34,400
-22.9%
0.00%
Q1 2022$56,000
+40.0%
44,644
+79.7%
0.00%
Q4 2021$40,000
-55.6%
24,844
-9.8%
0.00%
Q3 2021$90,000
-42.7%
27,544
+10.9%
0.00%
Q2 2021$157,00024,8440.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
Renaissance Technologies 1,242,370$9150.00%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,8250.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders